(Q34277813)

1 August 2017

1 reference

title

Management of antimicrobial use in the intensive care unit. (English)

1 reference

1 August 2017

1 reference

Alvarez-Lerma F

1

1 reference

1 August 2017

Palomar M

series ordinal

2

1 reference

1 August 2017

Grau S

series ordinal

3

1 reference

1 August 2017

publication date

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

61

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

763-775

1 reference

Once versus thrice daily gentamicin in patients with serious infections

1 August 2017

cites work

1 reference

12 December 2020

Penetration of antibiotics into respiratory secretions.

1 reference

12 December 2020

Epidemiological impact of prolonged systematic use of topical SDD on bacterial colonization of the tracheobronchial tree and antibiotic resistance. A three year study

1 reference

12 December 2020

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

1 reference

12 December 2020

Why don't physicians follow clinical practice guidelines? A framework for improvement

1 reference

12 December 2020

Changes in aerobic faecal bacterial flora of severely ill patients during antibiotic treatment.

1 reference

12 December 2020

Aerosol Polymyxin and Pneumonia in Seriously Ill Patients

1 reference

12 December 2020

An overview of mortality risk prediction in sepsis

1 reference

12 December 2020

Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC)

1 reference

12 December 2020

Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection.

1 reference

12 December 2020

Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents

1 reference

12 December 2020

A pharmacokinetic model-independent approach for estimating dose required to give desired steady-state trough concentrations of drug in plasma.

1 reference

12 December 2020

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

12 December 2020

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

1 reference

12 December 2020

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

1 reference

12 December 2020

Single daily doses of aminoglycosides

1 reference

12 December 2020

Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime

1 reference

12 December 2020

Single or multiple daily doses of aminoglycosides: a meta-analysis

1 reference

12 December 2020

Human pancreatic tissue concentration of bactericidal antibiotics

1 reference

12 December 2020

Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia

1 reference

12 December 2020

Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection

1 reference

12 December 2020

Antibiotic treatment for surgical peritonitis

1 reference

12 December 2020

Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group

1 reference

12 December 2020

The therapeutic monitoring of antimicrobial agents.

1 reference

12 December 2020

Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group

1 reference

12 December 2020

Clinical pharmacokinetics of continuous intravenous administration of penicillins

1 reference

12 December 2020

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

1 reference

12 December 2020

Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis

1 reference

12 December 2020

The pharmacodynamics of beta-lactams

1 reference

12 December 2020

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone

1 reference

12 December 2020

Antibiotic resistance associated with selective decontamination of the digestive tract.

1 reference

12 December 2020

Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at home.

1 reference

12 December 2020

Nosocomial infections in Spain: results of five nationwide serial prevalence surveys (EPINE Project, 1990 to 1994). Nosocomial Infections Prevalence Study in Spain

1 reference

12 December 2020

Damage to bacteria by antibiotics in vitro and its relevance to antimicrobial chemotherapy: a historical perspective

1 reference

12 December 2020

Ventilator-associated pneumonia due to Pseudomonas aeruginosa

1 reference

12 December 2020

Evaluation of vancomycin for therapy of adult pneumococcal meningitis

1 reference

12 December 2020

New intervention strategies for reducing antibiotic resistance

1 reference

12 December 2020

Antibiotic treatment of experimental Pseudomonas aeruginosa pneumonia in guinea pigs: comparison of aerosol and systemic administration

1 reference

12 December 2020

Optimal use of modern antibiotics: emerging trends

1 reference

12 December 2020

Emergence of gentamicin- and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment

1 reference

12 December 2020

Nosocomial gram-negative pneumonia in critically ill patients. A 3-year experience with a novel therapeutic regimen

1 reference

12 December 2020

Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model.

1 reference

12 December 2020

Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins

1 reference

12 December 2020

The pharmacodynamics of aminoglycosides

1 reference

12 December 2020

Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance

1 reference

12 December 2020

Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia

1 reference

12 December 2020

Monitoring of antimicrobial therapy by an integrated computer program

1 reference

12 December 2020

The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis

1 reference

12 December 2020

Antibiotic usage in an intensive care unit in a Danish university hospital

1 reference

12 December 2020

Recurrent Pseudomonas aeruginosa Pneumonia in an Intensive Care Unit

1 reference

12 December 2020

Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients

1 reference

12 December 2020

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

1 reference

12 December 2020

Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections

1 reference

12 December 2020

A computer-assisted management program for antibiotics and other antiinfective agents

1 reference

12 December 2020

[Anti-anaerobic activity of carbapenems]

1 reference

12 December 2020

10.2165/00003495-200161060-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1034074713

0 references

1 reference